Table 2 Clinical outcomes
Group | ||||
|---|---|---|---|---|
Outcomes | Control | NMES | p value | Effect size |
N | 30 | 30 | – | |
Incidence during the first 14 days, n (%) | ||||
• Sepsis | 13 (43%) | 16 (53%) | 0.44 | – |
• Septic shock | 9 (30%) | 10 (33%) | 0.78 | – |
• Multiple organ failure | 4 (13%) | 6 (20%) | 0.73 | – |
Time on MV, days | 15.5 [8.8–19] | 14 [8–18] | 0.65 | 0.1 |
Time on MV (survivor), days | 16 [9–19] | 14 [12–18] | 0.80 | 0.09 |
ICU length of stay, days | 19.5 [12–27.3] | 19 [10–26] | 0.58 | 0.28 |
ICU length of stay (survivor), days | 20 [15–31] | 23 [15–26] | 0.98 | 0.2 |
Hospital length of stay, days | 42 [20–56] | 34 [15–41.2] | 0.06 | 0.5 |
Hospital length of stay (survivor), days | 42 [23–53] | 35 [23–44] | 0.32 | 0.3 |
Mortality in ICU, n (%) | 3 (10%) | 5 (17%) | 0.71 | – |